These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17938025)

  • 1. Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption.
    Nguyen V; Cunningham BB; Eichenfield LF; Alió AB; Buka RL
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S123-5. PubMed ID: 17938025
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical safety of tazarotene in the treatment of plaque psoriasis.
    Marks R
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S25-32. PubMed ID: 9270553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medication of the month. Tazarotene 0.05%-0.1% (Zorac)].
    Henno A; Hua MT; de la Brassinne M
    Rev Med Liege; 2003 Nov; 58(11):706-8. PubMed ID: 14748200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescribe topical treatments for psoriasis].
    Lorette G; Fontès V
    Rev Prat; 2004 Jan; 54(1):40-2. PubMed ID: 15049598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tazarotene on ichthyosiform erythroderma of Tay's syndrome.
    Varghese VS; Rai R; Sundaram SV; Prabhu KS; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2007; 73(2):126-7. PubMed ID: 17456926
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrokeratoderma variabilis successfully treated with topical tazarotene.
    Yoo S; Simzar S; Han K; Takahashi S; Cotliar R
    Pediatr Dermatol; 2006; 23(4):382-5. PubMed ID: 16918639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I lamellar ichthyosis improved by tazarotene 0.1% gel.
    Marulli GC; Campione E; Chimenti MS; Terrinoni A; Melino G; Bianchi L
    Clin Exp Dermatol; 2003 Jul; 28(4):391-3. PubMed ID: 12823301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tazarotene 0.1% cream for the treatment of photodamage.
    Phillips TJ
    Skin Therapy Lett; 2004 Apr; 9(4):1-2. PubMed ID: 15146262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tazarotene in the treatment of psoriasis.
    Marks R
    Br J Dermatol; 1999 Apr; 140 Suppl 54():24-8. PubMed ID: 10731131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of Favre-Racouchot disease with 0.05% tazarotene gel.
    Rallis E; Karanikola E; Verros C
    Arch Dermatol; 2007 Jun; 143(6):810-2. PubMed ID: 17576962
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene.
    Cotellessa C; Cuevas-Covarrubias SA; Valeri P; Fargnoli MC; Peris K
    Acta Derm Venereol; 2005; 85(4):346-8. PubMed ID: 16191859
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro compatibility of tazarotene with other topical treatments of psoriasis.
    Hecker D; Worsley J; Yueh G; Lebwohl M
    J Am Acad Dermatol; 2000 Jun; 42(6):1008-11. PubMed ID: 10827404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichthyosis.
    Stege H; Hofmann B; Ruzicka T; Lehmann P
    Arch Dermatol; 1998 May; 134(5):640. PubMed ID: 9606345
    [No Abstract]   [Full Text] [Related]  

  • 14. [Topical tazarotene for severe congenital ichthyosis].
    Barbarot S; Acher-Chenebaux A; Stalder JF
    Ann Dermatol Venereol; 2006 Jan; 133(1):66-7. PubMed ID: 16495857
    [No Abstract]   [Full Text] [Related]  

  • 15. Tazarotene.
    Foster RH; Brogden RN; Benfield P
    Drugs; 1998 May; 55(5):705-11; discussion 712. PubMed ID: 9585866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on the use of topical tazarotene to treat squamous cell carcinoma in situ.
    Bardazzi F; Bianchi F; Parente G; Guareschi E; Landi C
    J Am Acad Dermatol; 2005 Jun; 52(6):1102-4. PubMed ID: 15928641
    [No Abstract]   [Full Text] [Related]  

  • 17. Tazarotene 0.1 percent cream fares better than erbium:YAG laser or incision and drainage in a patient with eruptive vellus hair cysts.
    Saks K; Levitt JO
    Dermatol Online J; 2006 Oct; 12(6):7. PubMed ID: 17083887
    [No Abstract]   [Full Text] [Related]  

  • 18. Lamellar ichthyosis treated with tazarotene 0.1% gel.
    Kundu RV; Garg A; Worobec SM
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S94-5. PubMed ID: 17052545
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
    Rigopoulos D; Gregoriou S; Katsambas A
    Acta Derm Venereol; 2007; 87(2):167-8. PubMed ID: 17340027
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic profile of tazarotene.
    Duvic M
    Cutis; 1998 Feb; 61(2 Suppl):22-6. PubMed ID: 9787988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.